1 1

HealthCert Education

Non-melanocytic lesions Part 2

Non-melanocytic lesions Part 2

"Non-Melanocytic Lesions Part 2" is an advanced course designed to refine healthcare professionals' skills in diagnosing and managing malignant keratinocytic lesions. The program focuses on squamous cell carcinoma (SCC), keratoacanthoma, basal cell carcinoma (BCC), and other malignant non-melanocytic skin conditions. With a focus on histological and dermoscopic insights, this course equips participants with the knowledge to differentiate between benign and malignant lesions, apply decision-making algorithms, and implement evidence-based treatments to improve patient outcomes.

time-icon 4.0 hrs EA | 6.0 hrs RP | 0.0 hrs OM
$195.00
$195.00
Sale Sold out

SHOP-A3HFD

View full details

  • FLEXIBLE TIMING

  • 100% ONLINE

  • accredited Course

  • Expert instructor

The Non-Melanocytic Lesions Part 2 course provides in-depth knowledge and practical tools for the identification, diagnosis, and management of malignant non-melanocytic lesions. This comprehensive unit emphasises dermoscopic evaluation, histological correlation, and evidence-based approaches.

This course explores the clinical, dermoscopic, and histological features of key malignant non-melanocytic skin lesions, including squamous cell carcinoma, basal cell carcinoma, and keratoacanthoma.
Key topics include:
- Squamous Cell Carcinoma (SCC)
- Differentiating SCC in situ (Bowen’s disease) from invasive SCC.
- Dermoscopic features of SCC, such as white circles, surface keratin, and polymorphic vessels.
- Diagnostic challenges in collision lesions and distinguishing SCC from actinic keratosis.
- Histological characteristics, including atypical keratinocytes, parakeratosis, and mitotic figures.
- Keratoacanthoma
- Recognising the architectural and cytological features of keratoacanthomas, including their symmetrical structure and central keratin-filled crater.
- Understanding their benign behaviour and management options.
- Basal Cell Carcinoma (BCC)
- Overview of BCC subtypes: nodular, pigmented, superficial, and aggressive forms such as infiltrative and morpheaform.
- Dermoscopic patterns, including fine arborizing vessels, translucent stroma, and clefting at the stromal-tumor interface.
- The importance of early detection and intervention for deep or aggressive BCC.
- Other Malignant Lesions
- Introduction to less common malignancies, such as Merkel cell carcinoma and cutaneous lymphoma.
- Dermoscopic and histopathological features for differential diagnosis.
- Practical Applications and Case Discussions
- Interactive case studies to reinforce learning and application of diagnostic algorithms.
- Evidence-based approaches to treatment and follow-up care.

By completing this course, participants will gain the expertise to accurately diagnose and manage malignant non-melanocytic lesions, reducing morbidity and improving patient outcomes. This program is essential for clinicians seeking advanced skills in dermoscopy and dermatopathology.

  1. Apply clinical and dermatoscopic information in evidence-based decision making with respect to skin lesions
  2. Define and use key terminology for dermatoscopy
  3. Apply decision algorithms in the diagnosis of both pigmented and non-pigmented skin lesions
  4. Define and use terminology used in dermatopathology
  5. Distinguish the histological features of common and less common benign and malignant non-melanocytic skin lesions

All degree qualified medical practitioners.

cpd hours image

CPD Hours:

  • Education hours:  4.0
  • Reviewing performance hours: 6.0
  • Measuring outcome hours:  0.0
cpd hours image

Accreditations:

Royal Australian College of General Practice (RACGP) #490766

Australian College of Rural and Remote Medicine (ACRRM) #31283

cpd hours image

Study Mode:

100% online

cpd hours image

Study duration:

10.0 hrs self-paced

cpd hours image

ABOUT THE PRESENTER

Professor Cliff Rosendahl and Dr Simon Clark

This course is presented by Professor Cliff Rosendahl (MBBS PhD) and Dr Simon Clark (MBChB FRCPA Specialist).

Cliff is the Professor and Course Coordinator MMed Skin Cancer Program School of Medicine, The University of Queensland. Cliff currently works in Brisbane as a primary care practitioner with a special interest in skin cancer.  He also has an interest in research as the clinical developer and Director of the Skin Cancer Audit Research Database (SCARD). His other main area of research has been in evaluating dermatoscopic clues for the diagnosis of both pigmented and non-pigmented skin malignancy in collaboration with colleagues at The University of Queensland, Australia and the Medical University of Vienna, Austria.

Simon is an Honorary Lecturer in Pathology, The University of Queensland. He runs the pathology component of the postgraduate certificate courses in skin cancer medicine at The University of Queensland and lectures in the Masters of Medicine course. He has been involved in dermatopathology education for more than 20 years, training registrars in dermatology, pathology and plastic surgery. One of the best known dermatopathologists in Australia, Simon was recently appointed a visiting professor in dermatology at the Tehran University of Medical Sciences.